How many insider declarations has Gagan Harsh Sharma filed?

Gagan Harsh Sharma has filed 3 public insider declarations with SEBI (PIT + SAST).

What is Gagan Harsh Sharma's role?

Gagan Harsh Sharma's reported role is not specified by the regulator across the filings.

Which companies does Gagan Harsh Sharma report trades for?

Gagan Harsh Sharma reports trades for Bliss GVS Pharma Limited.

← Executives ★ Sign in to follow

GH

Gagan Harsh Sharma

IN·SEBI (PIT + SAST)

Bliss GVS Pharma Limited

Cumul. flow

0

Total declarations

0

Company

—

▲ Purchases (0 ops.)

—

▼ Sales (0 ops.)

Discover the detailed record of transactions filed by Gagan Harsh Sharma. Director active across 1 company, notably Bliss GVS Pharma Limited. Aggregated, 3 reports have been logged. Activity tracked since 26 June 2025. The latest transaction was filed on 27 June 2025 (Purchase). Regulator: SEBI (PIT + SAST). All data is openly available.

Declarations3 total

●

Gagan Harsh Sharma

Executives27 Jun 2025Bliss GVS Pharma Limited

₹421,22814SEBI ↗

2,666 shares@ ₹158.008.1% of flowEquity SharesSEBI:9a5509ecf001cc4a45e85c0b5731ac6ada834afb

Ideal exit: 24 Mar 2026 (T+270)

●

Gagan Harsh Sharma

Executives25 Jun 2025Bliss GVS Pharma Limited

₹1M4SEBI ↗

7,500 shares@ ₹148.8021.3% of flowEquity SharesSEBI:08fc787eeae245382e49b64c55585a34636c850b

Ideal exit: 22 Mar 2026 (T+270)

●

Gagan Harsh Sharma

Executives26 Jun 2025Bliss GVS Pharma Limited

₹4M9SEBI ↗

24,819 shares@ ₹148.617170.6% of flowEquity SharesSEBI:988a6c73274170724029a0c561c9e19ba4801f95

Ideal exit: 23 Mar 2026 (T+270)

3 of 3 declarations

InsidersTradesSigma

← Executives ★ Sign in to follow

GH

Gagan Harsh Sharma

IN·SEBI (PIT + SAST)

Bliss GVS Pharma Limited

Cumul. flow

0

Total declarations

0

Company

—

▲ Purchases (0 ops.)

—

▼ Sales (0 ops.)

Discover the detailed record of transactions filed by Gagan Harsh Sharma. Director active across 1 company, notably Bliss GVS Pharma Limited. Aggregated, 3 reports have been logged. Activity tracked since 26 June 2025. The latest transaction was filed on 27 June 2025 (Purchase). Regulator: SEBI (PIT + SAST). All data is openly available.

Declarations3 total

●

Gagan Harsh Sharma

Executives27 Jun 2025Bliss GVS Pharma Limited

₹421,22814SEBI ↗

2,666 shares@ ₹158.008.1% of flowEquity SharesSEBI:9a5509ecf001cc4a45e85c0b5731ac6ada834afb